Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma

[1]  Y. Saeys,et al.  A scalable SCENIC workflow for single-cell gene regulatory network analysis , 2020, Nature Protocols.

[2]  J. Lee,et al.  Single-cell analysis of a mutant library generated using CRISPR-guided deaminase in human melanoma cells , 2020, Communications Biology.

[3]  Itai Yanai,et al.  Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas , 2020, Nature Biotechnology.

[4]  Ashley M. Laughney,et al.  Regenerative lineages and immune-mediated pruning in lung cancer metastasis , 2019, Nature Medicine.

[5]  James M. McFarland,et al.  Pan-cancer single cell RNA-seq uncovers recurring programs of cellular heterogeneity , 2019 .

[6]  J. Marine,et al.  Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities , 2019, Genes & development.

[7]  J. Barrett,et al.  Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma , 2019, Clinical Cancer Research.

[8]  Aviad Tsherniak,et al.  Extracting Biological Insights from the Project Achilles Genome-Scale CRISPR Screens in Cancer Cell Lines , 2019, bioRxiv.

[9]  S. Aerts,et al.  cisTopic: cis-regulatory topic modeling on single-cell ATAC-seq data , 2019, Nature Methods.

[10]  Lai Guan Ng,et al.  Dimensionality reduction for visualizing single-cell data using UMAP , 2018, Nature Biotechnology.

[11]  Monika S. Kowalczyk,et al.  A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade , 2018, Cell.

[12]  Mauro A. A. Castro,et al.  The chromatin accessibility landscape of primary human cancers , 2018, Science.

[13]  G. Wahl,et al.  Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity. , 2018, Cancer cell.

[14]  K. Flaherty,et al.  Toward Minimal Residual Disease-Directed Therapy in Melanoma , 2018, Cell.

[15]  P. Verstreken,et al.  A Single-Cell Transcriptome Atlas of the Aging Drosophila Brain , 2018, Cell.

[16]  P. Carmeliet,et al.  Phenotype molding of stromal cells in the lung tumor microenvironment , 2018, Nature Medicine.

[17]  T. Graeber,et al.  Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress. , 2018, Cancer cell.

[18]  Todd R. Golub,et al.  Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration , 2018, bioRxiv.

[19]  D. Bishop,et al.  β-Catenin–mediated immune evasion pathway frequently operates in primary cutaneous melanomas , 2018, The Journal of clinical investigation.

[20]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[21]  S. Shen-Orr,et al.  Alignment of single-cell trajectories to compare cellular expression dynamics , 2018, Nature Methods.

[22]  R. Young,et al.  High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma. , 2018, The Journal of investigative dermatology.

[23]  Kenneth L. Jones,et al.  AP-2α and AP-2β cooperatively orchestrate homeobox gene expression during branchial arch patterning , 2018, Development.

[24]  Shawn M. Gillespie,et al.  Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.

[25]  Wiktor Paskal,et al.  Intratumor and Intertumor Heterogeneity in Melanoma , 2017, Translational oncology.

[26]  Nicholas A. Sinnott-Armstrong,et al.  An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues , 2017, Nature Methods.

[27]  Hannah A. Pliner,et al.  Reversed graph embedding resolves complex single-cell trajectories , 2017, Nature Methods.

[28]  Ann E. Sizemore,et al.  Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells , 2017, Nature Genetics.

[29]  M. Esteller,et al.  Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma , 2017, BMC Medicine.

[30]  J. Aerts,et al.  SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.

[31]  Sydney M. Shaffer,et al.  Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance , 2017, Nature.

[32]  W. Pavan,et al.  TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF , 2017, PLoS genetics.

[33]  Mariella G. Filbin,et al.  Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq , 2017, Science.

[34]  Y. Saeys,et al.  SCORPIUS improves trajectory inference and identifies novel modules in dendritic cell development , 2016, bioRxiv.

[35]  L. Lagae,et al.  Time-lapse lens-free imaging of cell migration in diverse physical microenvironments. , 2016, Lab on a chip.

[36]  A. Anichini,et al.  NFATc2 is an intrinsic regulator of melanoma dedifferentiation , 2016, Oncogene.

[37]  Charles H. Yoon,et al.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.

[38]  J. Sosman,et al.  Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma , 2016, Cell.

[39]  R. Campbell,et al.  Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. , 2016, The Journal of clinical investigation.

[40]  J. Landsberg,et al.  MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment , 2015, Nature Communications.

[41]  D. Gautheret,et al.  New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis , 2015, Cell reports.

[42]  R. Young,et al.  CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer , 2015, Cell.

[43]  T. Nascimento.  Identification of Melanoma Stem Cells in Long-term Cultures and of SOX6 as a Specific Biomarker for these Stem Cells , 2015 .

[44]  Evan Z. Macosko,et al.  Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets , 2015, Cell.

[45]  S. Aerts,et al.  Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state , 2015, Nature Communications.

[46]  S. Aerts,et al.  Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells , 2015, eLife.

[47]  Z. Jia,et al.  Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer , 2015, British Journal of Cancer.

[48]  P. Meltzer,et al.  Antagonistic Cross-Regulation between Sox9 and Sox10 Controls an Anti-tumorigenic Program in Melanoma , 2015, PLoS genetics.

[49]  R. Scolyer,et al.  A novel hypoxia-associated subset of FN1highMITFlow melanoma cells: identification, characterization, and prognostic value , 2014, Modern Pathology.

[50]  G. Berx,et al.  Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression , 2014, Cell Death and Differentiation.

[51]  J. Lachuer,et al.  A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. , 2013, Cancer cell.

[52]  Timothy E. Reddy,et al.  Distinct properties of cell-type-specific and shared transcription factor binding sites. , 2013, Molecular cell.

[53]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[54]  Hubing Shi,et al.  MDM4 is a key therapeutic target in cutaneous melanoma , 2012, Nature Medicine.

[55]  R. Dummer,et al.  Systematic classification of melanoma cells by phenotype‐specific gene expression mapping , 2012, Pigment cell & melanoma research.

[56]  Dimitris Anastassiou,et al.  A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma , 2012, PloS one.

[57]  N. D. Clarke,et al.  Integrative model of genomic factors for determining binding site selection by estrogen receptor-α , 2010, Molecular systems biology.

[58]  K. Hoek,et al.  Cancer stem cells versus phenotype‐switching in melanoma , 2010, Pigment cell & melanoma research.

[59]  G. Hampton,et al.  Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration , 2008, Oncogene.

[60]  R. Dummer,et al.  In vivo switching of human melanoma cells between proliferative and invasive states. , 2008, Cancer research.

[61]  Georgia Panagiotakos,et al.  Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells , 2007, Nature Biotechnology.

[62]  A. Rao,et al.  The NFAT1 Transcription Factor is a Repressor of Cyclin A2 Gene Expression , 2007, Cell cycle.

[63]  A. Weeraratna,et al.  Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cells , 2006, Oncogene.

[64]  D. Schadendorf,et al.  Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. , 2006, Pigment cell research.

[65]  P. Oettgen,et al.  Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis. , 2006, Blood.

[66]  J. Baraban,et al.  A Dominant Negative Egr Inhibitor Blocks Nerve Growth Factor-Induced Neurite Outgrowth by Suppressing c-Jun Activation: Role of an Egr/c-Jun Complex , 2002, The Journal of Neuroscience.

[67]  E. Ziff,et al.  Mxi1 Is a Repressor of the c-myc Promoter and Reverses Activation by USF* , 1999, The Journal of Biological Chemistry.

[68]  L. Chin,et al.  An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the Yeast Transcriptional Repressor SIN3 , 1995, Cell.

[69]  L. Chin,et al.  Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. , 2017, Cancer discovery.

[70]  Christine Unger,et al.  In vitro cell migration and invasion assays. , 2013, Mutation research.

[71]  E. Zabarovsky,et al.  Tumor suppressor dual‐specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial‐mesenchymal transition (EMT)‐associated phenotype , 2012, International journal of cancer.

[72]  T. Sargent.  Transcriptional regulation at the neural plate border. , 2006, Advances in experimental medicine and biology.

[73]  W. Pavan,et al.  SOX10 mutation disrupts neural crest development in Dom Hirschsprung mouse model , 1998, Nature Genetics.